Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging findings of borderline lesions at high risk for progression to hypervascular classic hepatocellular carcinoma

Journal of Computer Assisted Tomography

Volumn 35, Issue 2, 2011, Pages 181-186

  Kobayashi, Satoshi ^a   Matsui, Osamu ^a   Gabata, Toshifumi ^a   Koda, Wataru ^a   Minami, Tetsuya ^a   Ryu, Yasuji ^a   Kawai, Keiichi ^a   Kozaka, Kazuto ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

angiography assisted CT; dysplastic nodule; Gd EOB DTPAYenhanced MRI; hepatocellular carcinoma; malignant foci

Indexed keywords

COMPUTERIZED TOMOGRAPHY; CONTRAST MEDIA; GADOLINIUM; MAGNETIC RESONANCE IMAGING; RISK ASSESSMENT;

ANGIOGRAPHY-ASSISTED COMPUTED TOMOGRAPHY; DIETHYLENETRIAMINE PENTA-ACETIC ACIDS; DYSPLASTIC NODULE; GADOLINIA; GD-EOB-DTPAYENHANCED MAGNETIC RESONANCE IMAGING; HEPATOBILIARY; HEPATOCELLULAR CARCINOMA; IMAGING FEATURES; MALIGNANT FOCUS; SIGNAL INTENSITIES;

ANGIOGRAPHY;

GADOXETIC ACID;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CANCER RISK; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DISEASE COURSE; FEMALE; HUMAN; IMAGE ENHANCEMENT; IMAGE QUALITY; LESIONS AND DEFECTS; LIVER CELL CARCINOMA; LIVER PARENCHYMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 79953822625     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/RCT.0b013e3182026f3b     Document Type: Article

References (19)

1. Parkin DM, Bray F, Ferlay J, et al. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94:153-156.
2. Satamoto M, Hirohashi S, Shimamoto Y. Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol. 1991;22:172-178.
3. Takayama T, Makuuchi M, Hirohashi S, et al. Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet. 1990;336:1150-1153. (Pubitemid 20362906)
4. International Working Party. Terminology of nodular hepatocellular lesions. Hepatology. 1995;22:983-993.
5. Hayashi M, Matsui O, Ueda K, et al. Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material. Radiology. 2001;225:143-149.
6. Chuma M, Sakamoto M, Yamazaki K, et al. Expression profiling in multistage hepatocarcinogenesis: identification of HSP 70 as a molecular marker of early hepatocellular carcinoma. Hepatology. 2003;37:198-207. (Pubitemid 36042161)
7. Takayasu K, Muramatsu Y, Mizuguchi Y, et al. Imaging of early hepatocellular carcinoma and adenomatous hyperplasia (dysplastic nodules) with dynamic CT and a combination of CT and angiography: experience with resected liver specimens. Intervirology. 2004;47:199-208. (Pubitemid 39279460)
8. Saito K, Kotake F, Ito N, et al. Gd-EOB-DTPA enhanced MRI for hepatocellular carcinoma: quantitative evaluation of tumor enhancement in hepatobiliary phase. Magn Reson Med Sci. 2005;4:1-9.
9. Bruix J, Sherman M. Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208-1236.
10. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907-1917. (Pubitemid 37518510)
11. Coleman WB. Mechanisms of human hepatocarcinogenesis. Curr Mol Med. 2003;3:573-588. (Pubitemid 37168599)
12. Efremidis SC, Hytiroglou P. The multistep process of hepatocarcinogenesis in cirrhosis with imaging correlation. Eur Radiol. 2002;12:753-764. (Pubitemid 36940129)
13. Matsui O, Kadoya M, Kameyama T, et al. Benign and malignant nodules in cirrhotic livers: distinction based on blood supply. Radiology. 1991;178:493-497.
14. Hayashi M, Matsui O, Ueda K, et al. Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium. Am J Roentogenol. 1999;172:969-976. (Pubitemid 29505622)
15. Ueda K, Terada T, Nakanuma Y, et al. Vascular supply in adenomatous hyperplasia of the liver and hepatocellular carcinoma: a morphometric study. Hum Pathol. 1992;23:619-626.
16. Nakamura K, Zen Y, Sato Y, et al. Vascular endothelial growth factor, its receptor Flk-1, and hypoxia inducible factor-1alpha are involved in malignant transformation in dysplastic nodules of the liver. Hum Pathol. 2007;38:1532-1546. (Pubitemid 47418965)
17. International Consensus Group for Hepatocellular Neoplasia. Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for Hepatocellular Neoplasia. Hepatology. 2009;49:658-664.
18. Yu JS, Chung JJ, Kim JH, et al. Hypervascular focus in the nonhypervascular nodule ("nodule-in-nodule") on dynamic computed tomography: imaging evidence of aggressive progression in hepatocellular carcinoma. J Comput Assist Tomogr. 2009;33:131-135.
19. Shinmura R, Matsui O, Kadoya M, et al. Detection of hypervascular malignant foci in borderline lesions of hepatocellular carcinoma: comparison of dynamic multi-detector row CT, dynamic MR imaging and superparamagnetic iron oxide-enhanced MR imaging. Eur Radiol. 2008;18:1918-1924.